Andrés Cervantes

机构：Universitat de València, Instituto de Salud Carlos III, INCLIVA Health Research Institute, Centro de Investigación Biomédica en Red de Cáncer · ORCID：0000-0003-3806-3691

发表论文 1119 篇 · 总被引 62906 次 · h-index 98

代表论文

• Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: A systematic review and diagnostic accuracy meta-analysis (2025 · Cancer Treatment Reviews · 被引 14)
• Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life (2025 · Cancer Treatment Reviews · 被引 14)
• Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer (2025 · ESMO Open · 被引 11)
• A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer (2025 · ESMO Open · 被引 4)
• PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA -Mutated Solid Tumors and in Preclinical Models (2025 · Clinical Cancer Research · 被引 3)
• Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons (2025 · ESMO Open · 被引 3)